AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,042.00p
   
  • Change Today:
    -164.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.29m
  • Volume: 2,329,887
  • Market Cap: £171,184m
  • RiskGrade: 123

Latest ShareCast News

AstraZeneca China president under investigation

By Iain Gilbert

Date: Wednesday 30 Oct 2024

(Sharecast News) - Drugmaker AstraZeneca revealed on Wednesday that Leon Wang, the president of AstraZeneca China, was under investigation by Chinese authorities.

AstraZeneca's nerve damage treatment recommended for approval in EU

By Benjamin Chiou

Date: Monday 21 Oct 2024

(Sharecast News) - Pharma titan AstraZeneca has announced that its Wainzua nerve damage treatment has been recommended for approval in the EU.

Hutchmed reports positive results from AstraZeneca lung cancer collaboration

By Josh White

Date: Wednesday 16 Oct 2024

(Sharecast News) - Hutchmed China announced positive results from its Savannah phase two trial on Wednesday, which studied the combination of 'Tagrisso', or osimertinib, and 'Orpathys', or savolitinib, in treating patients with epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC), who had high levels of MET overexpression or amplification and whose disease progressed after treatment with Tagrisso.

AstraZeneca enters into exclusive license agreem... 07-Oct-2024 ShareCast
AstraZeneca's Tagrisso gets new US lung cancer a... 26-Sep-2024 ShareCast
London close: Stocks finish higher after slew of... 23-Sep-2024 ShareCast
AstraZeneca breast cancer drug trial fails to im... 23-Sep-2024 ShareCast
AstraZeneca's inflammatory disease drug Fasenra ... 18-Sep-2024 ShareCast
London close: Stocks finish firmer in subdued tr... 13-Sep-2024 ShareCast
London close: Stocks mixed on latest UK jobs data 10-Sep-2024 ShareCast
AstraZeneca shares drop on lung cancer trial upd... 10-Sep-2024 ShareCast
London close: Stocks slip on relatively quiet Fr... 16-Aug-2024 ShareCast
AstraZeneca's Imfinzi gets fresh approval in the... 16-Aug-2024 ShareCast
AstraZeneca prices EUR 1.4bn eurobond offering 30-Jul-2024 ShareCast
London close: Stocks finish mixed at start of bu... 29-Jul-2024 ShareCast
AstraZeneca reports positive results from leukae... 29-Jul-2024 ShareCast
AstraZeneca gets positive feedback on possible I... 26-Jul-2024 ShareCast
London close: Stocks mixed on tsunami of updates... 25-Jul-2024 ShareCast
AstraZeneca hikes full-year guidance after stron... 25-Jul-2024 ShareCast
AstraZeneca endometrial cancer treatment recomme... 01-Jul-2024 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,042.00p
Change Today -164.00p
% Change -1.46 %
52 Week High 13,276.00
52 Week Low 9,501.00
Volume 2,329,887
Shares Issued 1,550.29m
Market Cap £171,184m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.03% below the market average92.03% below the market average92.03% below the market average92.03% below the market average92.03% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
6.17% above the market average6.17% above the market average6.17% above the market average6.17% above the market average6.17% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income
88.49% below the market average88.49% below the market average88.49% below the market average88.49% below the market average88.49% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
88.65% above the market average88.65% above the market average88.65% above the market average88.65% above the market average88.65% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average

What The Brokers Say

Strong Buy 9
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-24 22-Feb-24
Paid 09-Sep-24 25-Mar-24
Amount 100.00¢ 197.00¢

Trades for 31-Oct-2024

Time Volume / Share Price
16:09 179,211 @ 11,160.00p
16:51 488 @ 11,042.00p
16:51 142 @ 11,042.00p
16:35 3,725 @ 11,042.00p
16:35 75 @ 11,042.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page